The Impact of Digital Health Interventions for the Management of Type 2 Diabetes on Health and Social Care Utilisation and Costs: A Systematic Review Tiyi MorrisFiona AspinalManuel Gomes Systematic Review Open access 10 December 2022 Pages: 163 - 173
The Challenge for Orphan Drugs Remains: Three Case Studies Demonstrating the Impact of Changes to NICE Methods and Processes and Alternative Mechanisms to Value Orphan Products Dawn LeeGrant McCarthyFleur Chandler Original Research Article Open access 31 October 2022 Pages: 175 - 187
Estimating the Incidence-Based Cost of Illness Due to Hematopoietic Stem Cell Transplantation Using One-Year Insurance Claim Data in Korea Sol KwonHye-Young Kang Original Research Article Open access 28 September 2022 Pages: 189 - 197
A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada Anuja ChatterjeeGijs van de WeteringKavita Sail Original Research Article Open access 05 November 2022 Pages: 199 - 216
Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods R. Brett McQueenNicholas D. MendolaZoltán Kaló Original Research Article Open access 01 November 2022 Pages: 217 - 228
Cost-effectiveness Analysis of Ocrelizumab for the Treatment of Relapsing and Primary Progressive Multiple Sclerosis in Portugal Paulo MartinsBjörn VandewalleIsabel Monteiro Original Research Article Open access 01 December 2022 Pages: 229 - 241
A Budget Impact Model of Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with IgPro20 (Hizentra) Relative to Intravenous Immunoglobulin in the United States Rajiv MallickRashad CarltonJoris Van Stiphout Original Research Article Open access 09 February 2023 Pages: 243 - 255
Attributable Patient Cost of Antimicrobial Resistance: A Prospective Parallel Cohort Study in Two Public Teaching Hospitals in Ghana Evans OtiekuAma Pokuaa FennyUlrika Enemark Original Research Article Open access 24 January 2023 Pages: 257 - 271
Economic Evaluation of Nivolumab Versus Docetaxel for the Treatment of Advanced Squamous and Non-squamous Non-small Cell Lung Cancer After Prior Chemotherapy in China Shanlian HuZhiliu TangOrban Holdgate Original Research Article Open access 10 March 2023 Pages: 273 - 284
Cost-Utility Analysis of the Caresyntax Platform to Identify Patients at Risk of Surgical Site Infection Undergoing Colorectal Surgery Eoin MoloneyAtefeh MashayekhiMichael Branagan-Harris Original Research Article Open access 03 February 2023 Pages: 285 - 298
The Burden of Caring for Individuals with Tuberous Sclerosis Complex (TSC) Who Experience Epileptic Seizures: A Descriptive UK Survey Hanna SkrobanskiKishan VyasSiu Hing Lo Original Research Article Open access 09 February 2023 Pages: 299 - 312
A Framework for a Health Economic Evaluation Model for Patients with Sickle Cell Disease to Estimate the Value of New Treatments in the United States of America Aaron WinnAnirban BasuScott D. Ramsey Original Research Article Open access 11 February 2023 Pages: 313 - 320
The Cost-Effectiveness of a Dance and Yoga Intervention for Girls with Functional Abdominal Pain Disorders Anna PhilipsonAnna DubergLinda Ryen Original Research Article Open access 16 January 2023 Pages: 321 - 335